Cutaneous Mucormycosis Following a Bullous Pemphigoid Flare in a Chronic Lymphocytic Leukemia Patient on Ibrutinib

World Journal of Oncology
Matthew K SteinFereshteh Zare

Abstract

While the recent development of novel therapeutics in oncology, such as small molecule kinase inhibitors (SMKIs), has enabled our ability to target disease-specific molecular pathways, the prolonged impact of these agents on the immune system and infectious risk remains to be seen. We present a 68-year-old male with refractory chronic lymphocytic leukemia (CLL) on ibrutinib monotherapy for 3 years who developed extensive cutaneous mucormycosis following a severe bullous pemphigoid (BP) flare. He received amphotericin B for 4 weeks and was continued on posaconazole with resolution of his mucormycosis infection. Consistent with a growing evidence of literature identifying opportunistic fungal infections in patients on ibrutinib therapy, providers should be cognizant of medical comorbidities that may predispose to such infections and explore methods of prevention before starting ibrutinib and other SMKIs.

Citations

Nov 26, 2019·The Cancer Journal·Thomas J Kipps, Michael Y Choi
May 28, 2020·Mycoses·Amalia AnastasopoulouDimitrios P Kontoyiannis
Feb 1, 2019·BMJ Case Reports·Tajwar NasirJeremy S Brown
Jul 3, 2020·American Journal of Clinical Dermatology·Vincent SibaudLoic Ysebaert
Jun 12, 2020·Clinical Microbiology Reviews·Joshua S DavisMichael Boyle
Oct 18, 2019·Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'oto-rhino-laryngologie Et De Chirurgie Cervico-faciale·Marco A MascarellaNader Sadeghi
Nov 9, 2019·Blood Reviews·Rossana MaffeiRoberto Marasca
Jul 18, 2020·The American Journal of Dermatopathology·Marion MarcaillouBedane Christophe
Feb 14, 2021·Dermatologic Therapy·Lucía Quintana-CastanedoPedro Herranz-Pinto
Apr 30, 2021·IDCases·Katherine R SittigSudhir C Kumar
Oct 9, 2021·Journal of Cutaneous Pathology·Riyad N H SeervaiJonathan L Curry

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.